JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

Nature Reviews Drug Discovery 17, 78 (2018). doi:10.1038/nrd.2017.267 Author: Daniella M. Schwartz, Yuka Kanno, Alejandro Villarino, Michael Ward, Massimo Gadina & John J. O'Shea Nature Reviews Drug Discovery16, 843–862 (2017)In the version of this article that was originally published, there was an error in Figure 3 on page 847. In this figure, the structure attributed to the compound BMS-986165 is
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Corrigendum Source Type: research